Bio2Bedside: The Cell Therapy Cost-Reduction Playbook

In this episode, Boro Dropulić, PhD, MBA, sat down with Ben McLeod and Jeff Martin, PhD to discuss the challenges in cell therapy costing, innovative solutions, and the future of the field. Recorded live on Dec 4th, 2025.

Scroll to Top
Award for Lentiviral Vector Design and Manufacturing Company of the Year in Asia 2026, presented by Life Sciences Review APAC - Advancing Human Health

Vector BioMed Named 2026 Lentiviral Vector Design and Manufacturing Company of the Year in Asia